|
|
||||||||
Eur J Cardiothorac Surg 1998;13:57-65
© 1998 Elsevier Science NL
a Department of Thoracic and Cardiovascular Surgery, University of Essen, Hufelandstr. 55, D-45122 Essen, Germany
b Pharmacological Institute, University of Essen, Hufelandstr. 55, D-45122 Essen, Germany
c Diagnostic Laboratories of the Department of Internal Medicine (Cancer Research), University of Essen, Hufelandstr. 55, D-45122 Essen, Germany
Received 25 August 1997; received in revised form 18 November 1997; accepted 19 November 1997.
Corresponding author. Tel.: +49 201 7233596; fax: +49 201 7235931.
Objective: The definition of a reliable and generally accepted diagnostic standard for perioperative myocardial damage is desirable. Cardiac troponin I (cTnI) is highly specific for myocardial tissue and can be measured rapidly. The aim of our study was to evaluate the diagnostic potential of cTnI for myocardial lesions in patients undergoing coronary artery bypass surgery (CABG). Methods: A total of 119 patients with diffuse coronary artery disease were operated on using blood cardioplegia. Serial blood samples drawn before and after surgery were analyzed for the activity of creatine kinase MB isoenzyme (CKMB) and the concentrations of CKMB mass, cardiac troponins T and I. On the basis of the biochemical results (except cTnI) and the findings of electrocardiography/echocardiography, patients were classified and cTnI was studied for each group separately: group I, minor myocardial damage; group II, non-transmural infarction; group III, transmural infarction; and group IV, preoperative non-transmural infarction. Results: In 87 patients of group I (73.1%) cTnI levels remained low; 19 patients (16.0%) were assigned to group II, 8 patients (6.7%) to group III, and 5 patients (4.2%) to group IV. For discrimination of patients without and with perioperative myocardial infarction (PMI) by one cTnI determination, the use of cutoff values of 6.5 ng/ml at 8 h, 9.8 ng/ml at 12 h, and 11.6 ng/ml at 24 h after aortic unclamping resulted in a diagnostic efficiency of 88, 94 and 98%. Especially, a cTnI value at 24 h had a sensitivity of 100% and a specificity of 97%. Cardiac troponin levels at 24 h were found to correlate closely with the well-recognized 248 h area-under-the-curve (P<0.0001; R=0.993), making serial determinations unnecessary. Conclusions: cTnI qualifies as a marker for diagnosis of PMI and quantitation of the amount of myocardial damage, because of the availability of a quick diagnostic test with high specificity, the high diagnostic efficiency, and especially the sufficient information gained by a single determination 24 h after aortic unclamping.
Key Words: Perioperative myocardial damage Cardiac troponin I Cardiac troponin T Creatine kinase MB isoenzyme Blood cardioplegia Coronary artery surgery
This article has been cited by other articles:
![]() |
C. Simon, F. Capuano, A. Roscitano, U. Benedetto, C. Comito, and R. Sinatra Cardiac Troponin I vs EuroSCORE: Myocardial Infarction and Hospital Mortality Asian Cardiovasc Thorac Ann, April 1, 2008; 16(2): 97 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nesher, A. A. Alghamdi, S. K. Singh, J. Y. Sever, G. T. Christakis, B. S. Goldman, G. N. Cohen, F. Moussa, and S. E. Fremes Troponin after Cardiac Surgery: A Predictor or a Phenomenon? Ann. Thorac. Surg., April 1, 2008; 85(4): 1348 - 1354. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Capuano, C. Simon, A. Roscitano, G. Sclafani, E. Tonelli, and R. Sinatra Cardiac Troponin I Concentrations During On-Pump Coronary Artery Surgery Asian Cardiovasc Thorac Ann, December 1, 2007; 15(6): 502 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Meco, S. Cirri, C. Gallazzi, G. Magnani, and D. Cosseta Desflurane preconditioning in coronary artery bypass graft surgery: a double-blinded, randomised and placebo-controlled study Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 319 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Abramov, M. Abu-Tailakh, M. Frieger, A. Ganiel, D. Tuvbin, and A. Wolak Plasma Troponin Levels After Cardiac Surgery vs After Myocardial Infarction Asian Cardiovasc Thorac Ann, December 1, 2006; 14(6): 530 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tritapepe, V. De Santis, D. Vitale, M. Santulli, A. Morelli, I. Nofroni, P. E. Puddu, M. Singer, and P. Pietropaoli Preconditioning effects of levosimendan in coronary artery bypass grafting--a pilot study Br. J. Anaesth., June 1, 2006; 96(6): 694 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gurbuz, B. Emrecan, L. Yilik, I. Ozsoyler, M. Kestelli, C. Ozbek, and N. Karahan Intracoronary shunt reduces postoperative troponin leaks: a prospective randomized study Eur. J. Cardiothorac. Surg., February 1, 2006; 29(2): 186 - 189. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Botha, D. V. Nagarajan, P. S. Lewis, and J. Dunning Can cardiac troponins be used to diagnose a perioperative myocardial infarction post cardiac surgery? Interactive CardioVascular and Thoracic Surgery, September 1, 2004; 3(3): 442 - 449. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Steuer, T. Bjerner, O. Duvernoy, L. Jideus, L. Johansson, H. Ahlstrom, E. Stahle, and B. Lindahl Visualisation and quantification of peri-operative myocardial infarction after coronary artery bypass surgery with contrast-enhanced magnetic resonance imaging Eur. Heart J., August 1, 2004; 25(15): 1293 - 1299. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Thielmann, P. Massoudy, G. Marggraf, S. Knipp, A. Schmermund, J. Piotrowski, R. Erbel, and H. Jakob Role of troponin I, myoglobin, and creatine kinase for the detection of early graft failure following coronary artery bypass grafting Eur. J. Cardiothorac. Surg., July 1, 2004; 26(1): 102 - 109. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nesher, E. Zisman, T. Wolf, R. Sharony, G. Bolotin, M. David, G. Uretzky, and R. Pizov Strict Thermoregulation Attenuates Myocardial Injury During Coronary Artery Bypass Graft Surgery as Reflected by Reduced Levels of Cardiac-Specific Troponin I Anesth. Analg., February 1, 2003; 96(2): 328 - 335. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Nass and L. A. Fleisher Diagnosing Perioperative Myocardial Infarction in Cardioth oracic and Vascular Surgery Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2002; 6(3): 219 - 227. [Abstract] [PDF] |
||||
![]() |
S. Bruemmer-Smith, M. S. Avidan, B. Harris, S. Sudan, R. Sherwood, J. B. Desai, F. Sutherland, and J. Ponte Glucose, insulin and potassium for heart protection during cardiac surgery Br. J. Anaesth., April 1, 2002; 88(4): 489 - 495. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Holmvang, B. Jurlander, C. Rasmussen, J. J. Thiis, P. Grande, and P. Clemmensen Use of Biochemical Markers of Infarction for Diagnosing Perioperative Myocardial Infarction and Early Graft Occlusion After Coronary Artery Bypass Surgery Chest, January 1, 2002; 121(1): 103 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Klatte, B. R. Chaitman, P. Theroux, J. A. Gavard, K. Stocke, S. Boyce, C. Bartels, B. Keller, A. Jessel, and for the GUARDIAN Investigators Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release: Results from the GUARDIAN trial J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1070 - 1077. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Eigel, G. van Ingen, and S. Wagenpfeil Predictive value of perioperative cardiac Troponin I for adverse outcome in coronary artery bypass surgery Eur. J. Cardiothorac. Surg., September 1, 2001; 20(3): 544 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Ray, M. M. Hales, L. Brown, M. F. O'Brien, and E. G. Stafford Postoperatively administered aprotinin or epsilon aminocaproic acid after cardiopulmonary bypass has limited benefit Ann. Thorac. Surg., August 1, 2001; 72(2): 521 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Petzold, P. Feindt, U. Sunderdiek, U. Boeken, Y. Fischer, and E. Gams Heart-type fatty acid binding protein (hFABP) in the diagnosis of myocardial damage in coronary artery bypass grafting Eur. J. Cardiothorac. Surg., June 1, 2001; 19(6): 859 - 864. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Vermes, M. Mesguich, R. Houel, C. Soustelle, P. Le Besnerais, M.-L. Hillion, and D. Loisance Cardiac troponin I release after open heart surgery: a marker of myocardial protection? Ann. Thorac. Surg., December 1, 2000; 70(6): 2087 - 2090. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Parekh, B. Venkatesh, D. Cross, A. Leditschke, J. Atherton, W. Miles, A. Winning, A. Clague, and C. Rickard Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage J. Am. Coll. Cardiol., October 1, 2000; 36(4): 1328 - 1335. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Belhomme, J. Peynet, M. Louzy, J.-M. Launay, M. Kitakaze, and P. Menasche Evidence for Preconditioning by Isoflurane in Coronary Artery Bypass Graft Surgery Circulation, November 9, 1999; 100(90002): II-340 - 344. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wan, M. B. Izzat, T. W. Lee, I. Y.P. Wan, N. L.S. Tang, and A. P.C. Yim Avoiding cardiopulmonary bypass in multivessel CABG reduces cytokine response and myocardial injury Ann. Thorac. Surg., July 1, 1999; 68(1): 52 - 56. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Satre, L. Holmvang, G.S. Wagner, B. Lindahl, and L. Wallentin Reduction of myocardial damage by prolonged treatment with subcutaneous low molecular weight heparin in unstable coronary artery disease Eur. Heart J., May 1, 1999; 20(9): 645 - 652. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |